US3282927A
(en)
|
1964-05-21 |
1966-11-01 |
Bristol Myers Co |
5-phenyl-4-thiazolylpenicillins
|
JP2001247569A
(ja)
|
1999-08-12 |
2001-09-11 |
Japan Tobacco Inc |
ピロリジン誘導体又はピペリジン誘導体及びその医薬用途
|
AUPQ253199A0
(en)
|
1999-08-30 |
1999-09-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Non-prostanoid prostaglandin I2-agonist
|
ATE293101T1
(de)
|
2000-06-16 |
2005-04-15 |
Smithkline Beecham Plc |
Piperidine zur verwendung als orexin rezeptor antagonisten
|
AU2001296799A1
(en)
|
2000-10-06 |
2002-04-15 |
Neurogen Corporation |
Benzimidazole and indole derivatives as crf receptor modulators
|
DE60108420T2
(de)
|
2000-11-28 |
2005-12-22 |
Smithkline Beecham P.L.C., Brentford |
Morpholinderivate als antagonisten an orexinrezeptoren
|
WO2002089800A2
(en)
|
2001-05-05 |
2002-11-14 |
Smithkline Beecham P.L.C. |
N-aroyl cyclic amine derivatives as orexin receptor antagonists
|
AU2002253361B2
(en)
|
2001-05-05 |
2006-08-17 |
Smithkline Beecham P.L.C. |
N-aroyl cyclic amines
|
GB0115862D0
(en)
|
2001-06-28 |
2001-08-22 |
Smithkline Beecham Plc |
Compounds
|
IL159041A0
(en)
|
2001-06-28 |
2004-05-12 |
Smithkline Beecham Plc |
N-aroyl cyclic amine derivatives as orexin receptor antagonists
|
GB0124463D0
(en)
|
2001-10-11 |
2001-12-05 |
Smithkline Beecham Plc |
Compounds
|
GB0127145D0
(en)
|
2001-11-10 |
2002-01-02 |
Smithkline Beecham |
Compounds
|
GB0130335D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
GB0130393D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
DE10240818A1
(de)
|
2002-08-30 |
2004-05-13 |
Grünenthal GmbH |
Substituierte 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazol-Derivate
|
AU2003262516A1
(en)
|
2002-09-18 |
2004-04-08 |
Glaxo Group Limited |
N-aroyl cyclic amines as orexin receptor antagonists
|
GB0225884D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225938D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225944D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
PE20050226A1
(es)
|
2003-06-04 |
2005-05-18 |
Aventis Pharma Sa |
Productos aril-heteroaromaticos y composiciones que los contienen
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
BRPI0508263B8
(pt)
|
2004-03-01 |
2021-05-25 |
Idorsia Pharmaceuticals Ltd |
derivados de 1, 2, 3, 4-tetra-hidro-isoquinolina, composição farmacêutica, e, uso de derivado de 1, 2, 3, 4-tetra-hidro-isoquinolina
|
WO2005113522A1
(en)
|
2004-05-07 |
2005-12-01 |
Janssen Pharmaceutica, N.V. |
Azole carboxamide inhibitors of bacterial type iii protein secretion systems
|
EP1604989A1
(en)
|
2004-06-08 |
2005-12-14 |
Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft |
DPP-IV inhibitors
|
US20060019975A1
(en)
|
2004-07-23 |
2006-01-26 |
Pfizer Inc |
Novel piperidyl derivatives of quinazoline and isoquinoline
|
GB0510142D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds A1
|
HUP0500920A2
(en)
|
2005-10-05 |
2007-07-30 |
Richter Gedeon Nyrt |
Oxadiazole derivatives, process for their preparation and their use
|
UA93903C2
(ru)
|
2006-03-15 |
2011-03-25 |
Актелион Фармасьютикалз Лтд |
Производные тетрагидроизохинолина для повышения функции памяти
|
EP2049110B1
(en)
|
2006-07-14 |
2014-08-20 |
Merck Sharp & Dohme Corp. |
Bridged diazepan orexin receptor antagonists
|
BRPI0715893A2
(pt)
|
2006-08-15 |
2013-09-17 |
Actelion Pharmaceuticals Ltd |
composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono
|
JP2010504957A
(ja)
|
2006-09-29 |
2010-02-18 |
アクテリオン ファーマシューティカルズ リミテッド |
3−アザ−ビシクロ[3.1.0]ヘキサン誘導体
|
PE20081229A1
(es)
|
2006-12-01 |
2008-08-28 |
Merck & Co Inc |
Antagonistas de receptor de orexina de diazepam sustituido
|
ATE496043T1
(de)
|
2006-12-01 |
2011-02-15 |
Actelion Pharmaceuticals Ltd |
3-heteroaryl (amino bzw. amido)-1- (biphenyl bzw. phenylthiazolyl) carbonylpiperdinderivate als orexinrezeptor-inhibitoren
|
AR064561A1
(es)
|
2006-12-28 |
2009-04-08 |
Actelion Pharmaceuticals Ltd |
Derivados de 2-aza-biciclo[3.1.0]hexano y su uso en la preparacion de un medicamento para el tratamiento de enfermedades relacionadas con disfunciones generales del sistema de la orexina.
|
WO2008087611A2
(en)
|
2007-01-19 |
2008-07-24 |
Actelion Pharmaceuticals Ltd |
Pyrrolidine- and piperidine- bis-amide derivatives
|
CL2008000836A1
(es)
|
2007-03-26 |
2008-11-07 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de tiazolidina, antagonistas del receptor de orexina; composicion farmaceutica que los comprende; y su uso en el tratamiento de neurosis emocional, depresion grave, trastornos psicoticos, alzheimer, parkinson, dolor, entre otras.
|
EP2155739B1
(en)
|
2007-05-14 |
2010-10-06 |
Actelion Pharmaceuticals Ltd. |
2-cyclopropyl-thiazole derivatives
|
US7741347B2
(en)
|
2007-05-17 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
EP2150115B1
(en)
*
|
2007-05-23 |
2013-09-18 |
Merck Sharp & Dohme Corp. |
Cyclopropyl pyrrolidine orexin receptor antagonists
|
GB0712888D0
(en)
|
2007-07-03 |
2007-08-15 |
Glaxo Group Ltd |
Novel compounds
|
BRPI0812981A2
(pt)
|
2007-07-03 |
2014-12-16 |
Glaxo Group Ltd |
Derivados de piperidina úteis como antagonistas dos receptores de orexina
|
CA2691373A1
(en)
|
2007-07-03 |
2009-01-08 |
Actelion Pharmaceuticals Ltd |
3-aza-bicyclo[3.3.0]octane compounds
|
WO2009016560A2
(en)
|
2007-07-27 |
2009-02-05 |
Actelion Pharmaceuticals Ltd |
Trans-3-aza-bicyclo[3.1.0]hexane derivatives
|
EP2183246A2
(en)
|
2007-07-27 |
2010-05-12 |
Actelion Pharmaceuticals Ltd. |
2-aza-bicyclo-[3.3.0]-octane derivatives
|
AR067665A1
(es)
|
2007-07-27 |
2009-10-21 |
Actelion Pharmaceuticals Ltd |
Derivados de trans-3- aza-biciclo ( 3.1.0) hexano
|
US8288411B2
(en)
|
2007-09-24 |
2012-10-16 |
Actelion Pharmaceuticals Ltd. |
Pyrrolidines and piperidines as orexin receptor antagonists
|
PE20091010A1
(es)
|
2007-10-10 |
2009-08-08 |
Actelion Pharmaceuticals Ltd |
Derivados de tetrahidroquinolina
|
BRPI0821115A8
(pt)
|
2007-12-18 |
2017-12-26 |
Actelion Pharmaceuticals Ltd |
Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
|
JP5395808B2
(ja)
*
|
2007-12-21 |
2014-01-22 |
エフ.ホフマン−ラ ロシュ アーゲー |
オレキシン受容体アンタゴニストとしてのヘテロアリール誘導体
|
ATE555107T1
(de)
|
2008-02-21 |
2012-05-15 |
Actelion Pharmaceuticals Ltd |
2-aza-bicyclo-ä2,2,1-üheptan-derivate
|
GB0806536D0
(en)
|
2008-04-10 |
2008-05-14 |
Glaxo Group Ltd |
Novel compounds
|
US20110105491A1
(en)
|
2008-07-07 |
2011-05-05 |
Hamed Aissaoui |
Thiazolidine compounds as orexin receptor antagonists
|
WO2010038200A1
(en)
|
2008-10-01 |
2010-04-08 |
Actelion Pharmaceuticals Ltd |
Oxazolidine compounds as orexin receptor antagonists
|
EP2334643A1
(en)
|
2008-10-14 |
2011-06-22 |
Actelion Pharmaceuticals Ltd. |
Phenethylamide derivatives and their heterocyclic analogues
|
US8710076B2
(en)
|
2008-10-21 |
2014-04-29 |
Merck Sharp & Dohme Corp. |
2,5-disubstituted piperidine orexin receptor antagonists
|
EP2358713A1
(en)
|
2008-11-26 |
2011-08-24 |
Glaxo Group Limited |
Imidazopyridazine derivatives acting as orexin antagonists
|
JP2012509910A
(ja)
|
2008-11-26 |
2012-04-26 |
グラクソ グループ リミテッド |
新規の化合物
|
WO2010060471A1
(en)
|
2008-11-26 |
2010-06-03 |
Glaxo Group Limited |
Piperidine derivatives useful as orexin receptor antagonists
|
WO2010063663A1
(en)
|
2008-12-02 |
2010-06-10 |
Glaxo Group Limited |
N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
|
CA2745420A1
(en)
|
2008-12-02 |
2010-06-10 |
Glaxo Group Limited |
N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0] hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
|
GB0823467D0
(en)
|
2008-12-23 |
2009-01-28 |
Glaxo Group Ltd |
Novel Compounds
|
CA2756780A1
(en)
|
2009-04-03 |
2010-10-07 |
Merck Sharp & Dohme Corp. |
Renin inhibitors
|
JP2012524760A
(ja)
|
2009-04-24 |
2012-10-18 |
グラクソ グループ リミテッド |
オレキシンアンタゴニストとして使用される3−アザビシクロ[4.1.0]ヘプタン
|
KR101444559B1
(ko)
|
2009-06-09 |
2014-09-26 |
액테리온 파마슈티칼 리미티드 |
불화 아미노트리아졸 유도체
|
EP2275421A1
(en)
*
|
2009-07-15 |
2011-01-19 |
Rottapharm S.p.A. |
Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
|
JP5847087B2
(ja)
|
2009-10-23 |
2016-01-20 |
ヤンセン ファーマシューティカ エヌ.ベー. |
オレキシン受容体調節因子としての縮合複素環式化合物
|
JP5848251B2
(ja)
|
2009-10-23 |
2016-01-27 |
ヤンセン ファーマシューティカ エヌ.ベー. |
オレキシン受容体調節因子としての縮合複素環式化合物
|
EP2491038B1
(en)
|
2009-10-23 |
2016-04-06 |
Janssen Pharmaceutica N.V. |
Disubstituted octahy - dropyrrolo [3,4-c]pyrroles as orexin receptor modulators
|
EP2526092B1
(en)
|
2010-01-19 |
2014-08-06 |
Amgen Inc. |
Amino heteroaryl compounds as beta-secretase modulators and methods of use
|
US8895606B2
(en)
|
2010-08-24 |
2014-11-25 |
Actelion Pharmaceuticals Ltd. |
Proline sulfonamide derivatives as orexin receptor antagonists
|
CN103249730A
(zh)
|
2010-09-24 |
2013-08-14 |
百时美施贵宝公司 |
丙型肝炎病毒抑制剂
|
US9242970B2
(en)
|
2010-11-10 |
2016-01-26 |
Actelion Pharmaceuticals Ltd. |
Lactam derivatives useful as orexin receptor antagonists
|
CN103380130B
(zh)
|
2011-02-18 |
2015-06-17 |
埃科特莱茵药品有限公司 |
用作为食欲素拮抗剂的新颖的吡唑和咪唑衍生物
|
US9150566B2
(en)
|
2011-11-08 |
2015-10-06 |
Actelion Pharmaceuticals Ltd. |
2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonists
|
EA029899B1
(ru)
|
2012-06-04 |
2018-05-31 |
Идорсиа Фармасьютиклз Лтд |
Производные бензимидазол-пролина
|
WO2014057435A1
(en)
|
2012-10-10 |
2014-04-17 |
Actelion Pharmaceuticals Ltd |
Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero )aryl)-pyrrolidin-1-yl]-methanone derivatives
|
CA2902135A1
(en)
|
2013-03-12 |
2014-09-18 |
Actelion Pharmaceuticals Ltd |
Azetidine amide derivatives as orexin receptor antagonists
|
TWI664177B
(zh)
|
2013-12-03 |
2019-07-01 |
瑞士商愛杜西亞製藥有限公司 |
晶形
|
UA119151C2
(uk)
|
2013-12-03 |
2019-05-10 |
Ідорсія Фармасьютікалз Лтд |
КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
|
DK3077391T3
(en)
|
2013-12-04 |
2018-10-22 |
Idorsia Pharmaceuticals Ltd |
USE OF BENZIMIDAZOLE PROLINE DERIVATIVES
|